Myovant Sciences Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Myovant Sciences Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $10.71 per share as of 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2022-05-11
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $10.71.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $9.90.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $9.25.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $14.46.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2022-03-31 | $10.71 10-K · filed 2022-05-11 |
| 2021-03-31 | $9.90 10-K · filed 2022-05-11 |
| 2020-03-31 | $9.25 10-K · filed 2021-05-11 |
| 2019-03-31 | $14.46 10-K · filed 2020-05-18 |
| 2018-03-31 | $9.84 10-K · filed 2020-05-18 |
| 2017-03-31 | $5.06 10-K · filed 2020-05-18 |
| 2016-03-31 | $0.00 10-K · filed 2019-05-24 |